Deceased donor kidney transplantation across donor-specific antibody barriers: predictors of antibody-mediated rejection

Abstract

IA-based desensitization failed to prevent ABMR in a considerable number of DSA+ recipients. Assessing DSA MFI may help stratify risk of rejection, supporting its use as a guide to organ allocation and individualized treatment.